Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials
Article in BMC Pharmacology and Toxicology (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Roles of biochemistry data, lifestyle, and inflammation in identifying abnormal renal function in old Chinese
Article in World Journal of Clinical Cases (October 2023)
Cardiovascular Safety Evaluation of Febuxostat and Allopurinol: Findings from the FDA Adverse Event Reporting System
Article in Journal of Clinical Medicine (September 2023)